Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4918 total record number 290 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 44 out of 492
4918 citations found

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Dolphin leukocytes exhibit an attenuated cytokine response and increase heme oxygenase activity upon exposure to lipopolysaccharides

Reyes-Ramos, CA;Ramírez-Jirano, LJ;Bitzer-Quintero, OK;Vázquez-Medina, JP;Gaxiola-Robles, R;Zenteno-Savín, T;

Product: LPS from Escherichia coli O55:B5

  • … For expression analysis, cells were harvested in 0.5 mL of RNAlater™ (Invitrogen™) and stored at -80 °C until analyzed. Escherichia coli LPS (O55:B5; List Biologicals, Campbell, CA, USA) was purchased from List Biologicals (Campbell, CA, USA) and diluted in RPMI culture media …

    Product #203A – LPS from Escherichia coli O55:B5

Neurotrophic factors loaded TGN-modified chitosan nanoparticles ameliorate symptoms of MS through GATA3/FOXP3 and targeting Th1/2cells pathways

Khodakarimi, S;Zarebkohan, A;Mohaddes, G;Shiri-Shahsavari, M;Omrani, M;Sepasi, T;Beyrampour-Basmenj, H;Ebrahimi-Kalan, A;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Abnormal immune system response in the brain of women with Fibromyalgia after experimental endotoxin challenge

Mueller, C;Jordan, I;Jones, C;Lawson, P;Younger, JW;

Product: LIST™ HPT™ from Escherichia coli O113

  • 2.3.2. Lipopolysaccharide preparation and administration

    LPS doses were prepared in the UAB CRU using an aseptic, no-touch technique. LPS (E. coli Type 0113 Clinical Center Reference Endotoxin) was manufactured by List Biological Laboratories, Inc. The Lot #94332B1 vials containing 1.0 mcg endotoxin were reconstituted to 1.0mcg/1.0 mL, using sterile water. 0.5 mL was drawn and diluted with 9.5 mL of sterile water to produce a 50 ng/mL solution for dosing. Dosages were drawn at 0.4 ng/kg (FM N = 7; HC N = 7) or 0.3 ng/kg (FM N = 5; HC N = 6) body weight. Finally, the dose was diluted in 30 mL sterile saline for administration.

    Product #9433 – GMP LPS Lipopolysaccharide List™ Hpt™ From Escherichia Coli Type O113

Inhalable vaccine of bacterial culture supernatant extract mediates protection against fatal pulmonary anthrax

Zhai, LN;Zhao, Y;Song, XL;Qin, TT;Zhang, ZJ;Wang, JZ;Sui, CY;Zhang, LL;Lv, M;Hu, LF;Zhou, DS;Fang, TY;Yang, WH;Wang, YC;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

  • Culture supernatant extract anthrax vaccine and its liquid and dry powder formulations preparation and characterization

    … Total protein concentrations of the CSE vaccine were measured by bicinchoninic acid assay (BCA, Gene-Star, Beijing, China). An enzyme-linked immunosorbent assay (ELISA, Dakewe, Beijing, China) was used to quantify the PA protein in the CSE vaccine according to a previously method [Citation20]. Serially diluted commercial recombinant PA (rPA, 171E, List Labs, Campbell, CA, USA) was the reference standard. …

    Product #171E – Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Product: LIST™ HPT™ from Escherichia coli O113

  • Experimental Human Endotoxemia (IV LPS Administration)

    … Following that, it was continuously given at a rate of 150mL/h for the remaining duration of the experiment. Promptly after prehydration, a bodyweight-adjusted bolus dose of 1ng/kg LPS (Escherichia coli-derived, Type O0113, lot no.94332B1; List Biological Laboratories, Campbell, CA, USA) was administered. Blood samples were serially obtained to construct time-concentration curves of circuiting cytokines (Jansen et al., 2022). Temperature and cardiovascular monitoring (blood pressure and heart rate) and sickness symptoms (headache, muscle pain, back pain, nausea, shivers and vomiting were recorded throughout the whole experiment with intervals of 30 minutes. …

    Product #9433 – GMP LPS Lipopolysaccharide List™ Hpt™ From Escherichia Coli Type O113

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

Inverse agonism of lysophospholipids with cationic head groups at Gi-coupled receptor GPR82

Yasuda, D;Hamano, F;Masuda, K;Dahlström, M;Kobayashi, D;Sato, N;Hamakubo, T;Shimizu, T;Ishii, S;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

LPCAT2 Regulates CD14 Expression During Macrophage Inflammatory Response to E. coli O111:B4

Poloamina, V;Abate, W;Fejer, G;Jackson, S;

Product: LPS from Escherichia coli J5 (Rc)